Dopamine-induced apoptosis in human melanocytes involves generation of reactive oxygen species

British Journal of Dermatology

Volumn 154, Issue 6, 2006, Pages 1071-1079

  Chu, C Y ^a   Liu, Y L ^a   Chiu, H C ^a   Jee, S H ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antioxidant; Apoptosis; Dopamine; Melanocyte; Monoamine; Reactive oxygen species

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ACETYLCYSTEINE; ADRENALIN; DOPAMINE; MONOAMINE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; SEROTONIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MELANOCYTE; PREPUCE; PRIORITY JOURNAL; VITILIGO;

ACETYLCYSTEINE; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; HUMANS; MALE; MELANOCYTES; NOREPINEPHRINE; REACTIVE OXYGEN SPECIES; SEROTONIN;

EID: 33646588364     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07293.x     Document Type: Article

References (37)

1. Huang CL Nordlund JJ Boissy R Vitiligo: a manifestation of apoptosis Am J Clin Dermatol 2002 3 301 8
2. Majumder PP Genetics and prevalence of vitiligo vulgaris In Vitiligo Hann S-K Nordlund JJ eds 1st edn Oxford Blackwell Scientific Publications 2000 18 20
3. Bolognia JL Pawelek JM Biology of hypopigmentation J Am Acad Dermatol 1988 19 217 55
4. Ortonne JP Bose SK Vitiligo: where do we stand? Pigment Cell Res 1993 6 61 72
5. Kovacs SO Vitiligo. J Am Acad Dermatol 1998 38 647 66
6. Morrone A Picardo M de Luca C et al. Catecholamines and vitiligo Pigment Cell Res 1992 5 65 9
7. Papadopoulos L Bor R Legg C Hawk JL Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology Clin Exp Dermatol 1998 23 243 8
8. Salzer BA Schallreuter KU Investigation of the personality structure in patients with vitiligo and a possible association with impaired catecholamine metabolism Dermatology 1995 190 109 15
9. Cucchi ML Frattini P Santagostino G Orecchia G Higher plasma catecholamine and metabolite levels in the early phase of nonsegmental vitiligo Pigment Cell Res 2000 13 28 32
10. Schallreuter-Wood KU Wood JM Catecholamines in vitiligo Dermatology 1996 192 191 2
11. Cucchi ML Frattini P Santagostino G et al. Catecholamines increase in the urine of non-segmental vitiligo especially during its active phase Pigment Cell Res 2003 16 111 16
12. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase J Inves Dermatol Symp Proc 1999 4 91 6
13. Centeno F Mora A Fuentes JM Partial lithium-associated protection against apoptosis induced by C2-ceramide in cerebellar granule neurons Neuroreport 1998 9 4199 203
14. Dell'Anna ML Urbanelli S Mastrofrancesco A et al. Alterations of mitochondria in peripheral blood mononuclear cells of vitiligo patients Pigment Cell Res 2003 16 553 9
15. Cheng FC Kuo JS Chang WH et al. Rapid and reliable high-performance liquid chromatographic method for analysing human plasma serotonin, 5-hydroxyindoleacetic acid, homovanillic acid and 3,4-dihydroxyphenylacetic acid J Chromatogr 1993 617 227 32
16. Reedy MV Parichy DM Erickson CA et al. Regulation of melanoblast migration and differentiation In The Pigmentary System: Physiology and Pathophysiology Nordlund JJ Boissy RE Hearing VJ King RA Ortonne JP eds New York Oxford University Press 1998 75 96
17. Scarparo AC Visconti MA Oliveira AR Castrucci AML Adrenoceptors in normal and malignant human melanocytes Arch Dermatol Res 2000 292 265 7
18. Schallreuter KU Korner C Pittelkow MR et al. The induction of the alpha-1-adrenoceptor signal transduction system on human melanocytes Exp Dermatol 1996 5 20 3
19. Schallreuter KU Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis J Inves Dermatol Symp Proc 1997 2 37 40
20. Schallreuter KU Wood JM Lemke R et al. Production of catecholamines in the human epidermis Biochem Biophys Res Commun 1992 189 72 8
21. Johansson O Lui P-Y Bondesson L et al. A serotonin-like immunoreactivity is present in human cutaneous melanocytes J Invest Dermatol 1998 111 1010 14
22. Slominski A Pisarchik A Semak I et al. Serotoninergic and melatoninergic systems are fully expressed in human skin FASEB J 2002 16 896 8
23. Slominski A Pisarchik A Zbytek B et al. Functional activity of serotoninergic and melatoninergic systems expressed the skin J Cell Physiol 2003 196 144 53
24. 2-adrenoceptor signal promote pigmentation in human epidermal melanocytes J Invest Dermatol 2004 123 346 53
25. Zilkha-Falb R Ziv I Nardi N et al. Monoamine-induced apoptotic neuronal cell death Cell Mol Neurobiol 1997 17 101 18
26. Noh JS Kim EY Kang JS et al. Neurotoxic and neuroprotective actions of catecholamines in cortical neurons Exp Neurol 1999 159 217 24
27. McLaughlin BA Nelson D Erecińska M Chesselet MF Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor J Neurochem 1998 70 2406 15
28. Junn E Mouradian M Apoptotic signalling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases J Neurochem 2001 78 374 83
29. Offen D Ziv I Sternin H et al. Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease Exp Neurol 1996 141 32 9
30. Kuhn DM Arthur RE Jr. Dopamine inactivates tryptophan hydroxylase and forms a redox-cycling quinoprotein: possible endogenous toxin to serotonin neurons J Neurosci 1998 18 7111 17
31. Jones DC Gunasekar PG Borowitz JL Isom GE Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiated PC12 cells J Neurochem 2000 74 2296 304
32. Colombo C Cosentino M Marino F et al. Dopaminergic modulation of apoptosis in human peripheral blood mononuclear cells: possible relevance for Parkinson's disease Ann N Y Acad Sci 2003 1010 679 82
33. Wick MM Dopamine: a novel antitumor agent active against B-16 melanoma in vivo J Invest Dermatol 1978 71 163 4
34. Yang F Sarangarajan R Le Poole IC et al. The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity J Invest Dermatol 2000 114 157 64
35. Maresca V Roccella M Roccella F et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo J Invest Dermatol 1997 109 310 13
36. Schallreuter KU Wood JM Ziegler I et al. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo Biochim Biophys Acta 1994 1226 181 92
37. Dell'Anna ML Maresca V Briganti S et al. Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo J Invest Dermatol 2001 117 908 13